Colorectal Cancer Screening

Colorectal Cancer Screening provides a complete overview of colorectal cancer screening, from epidemiology and molecular abnormalities, to the latest screening techniques such as stool DNA and FIT, Computerized Tomography (CT) Colonography, High Definition Colonoscopes and Narrow Band Imaging. As the text is devoted entirely to CRC screening, it features many facts, principles, guidelines and figures related to screening in an easy access format. This volume provides a complete guide to colorectal cancer screening which will be informative to the subspecialist as well as the primary care practitioner. It represents the only text that provides this up to date information about a subject that is continually changing. For the primary practitioner, information on the guidelines for screening as well as increasing patient participation is presentedd. For the subspecialist, information regarding the latest imaging techniques as well as flat adenomas and chromoendoscopy are covered. The section on the molecular changes in CRC will appeal to both groups. The text includes up to date information about colorectal screening that encompasses the entire spectrum of the topic and features photographs of polyps as well as diagrams of the morphology of polyps as well as photographs of CT colonography images. Algorithms are presented for all the suggested guidelines. Chapters are devoted to patient participation in screening and risk factors as well as new imaging technology. This useful volume explains the rationale behind screening for CRC. In addition, it covers the different screening options as well as the performance characteristics, when available in the literature, for each test. This volume will be used by the sub specialists who perform screening tests as well as primary care practitioners who refer patients to be screened for colorectal cancer.

This book offers a self-contained review of the theoretical and practical basis of colorectal cancer screening. Colorectal cancer is currently the fourth leading cause of cancer deaths worldwide and represents a significant burden for both public health and health care systems. However, colorectal cancer deaths can be prevented using effective screening, and many countries and regions have launched population colorectal cancer screening programs. This book covers various essential aspects of colorectal cancer screening, including the epidemiology of colorectal cancer, the various screening and diagnostic tests or exams, quality issues in colorectal cancer screening, necessary infrastructures, the evaluation of effectiveness, and economic appraisals of screening programs. Focusing on organized screening, in which various quality indicators can easily monitored and effectiveness is more likely to be evaluated, it discusses the basics of screening theory and the natural history of colorectal neoplasms, to help readers understand the rationale behind cancer screening. Lastly, it features international consensus and guidelines on colorectal cancer screening to highlight the current trends in the field. This comprehensive book on recent technological developments and conceptual advances in colorectal cancer screening is a valuable resource for public health workers and clinicians alike.

A Working Group of 23 independent experts from 15 countries, convened by the International Agency for Research on Cancer (IARC) in November 2017, reviewed the scientific evidence and assessed the cancer-preventive and adverse effects of various methods of screening for colorectal cancer. Colorectal cancer is the third most common cancer in men and the second most common in women worldwide, and represents more than 10% of the global cancer burden. This publication provides evidence-based evaluations of the effectiveness of colorectal cancer screening in reducing colorectal cancer incidence and mortality. The Working Group also reviewed the body of evidence on the comparison of endoscopic and stool-based techniques, on the determinants of participation in screening programs, and on the most mature emerging techniques that may be alternatives to current practices for colorectal cancer screening, as well as presenting the different categories of high-risk populations and the surveillance strategies for such individuals.

Dr. Soetikno has organized a comprehensive issue devoted to the detection and diagnosis of non-polypoid colorectal neoplasms with special emphasis on sessile or flat colon adenoma. Top experts in the field have supplied the latest clinical information in the following areas: Non-Polypoid Colorectal Neoplasms in Ulcerative Colitis; Detection and Diagnosis of Non-Polypoid Colorectal Neoplasms; Image-Enhanced Endoscopy to Detect and Diagnose Non-Polypoid Colorectal Neoplasms; CT Colonography and Non-Polypoid Colorectal Neoplasms, as well as Endoscopic Mucosal Resection of Non-Polypoid Colorectal Neoplasms. This issue is an important one as there are not many references on the topics that are as comprehensive.

Recoge: 1. Introduction -- 2. Organisation -- Guiding principles for organising a colorectal cancer screening programme -- 3. Evaluation and interpretation of screening outcomes -- 4. Faecal occult blood testing -- 5. Quality assurance in endoscopy in colorectal cancer screening and diagnosis -- 6. Professional requirements and training -- 7. Quality assurance in pathology in colorectal cancer screening and diagnosis -- 8. Management of lesions detected in colorectal cancer screening -- 9. Colonoscopic surveillance following adenoma removal --10. Communication -- Appendices.

The IOM's National Cancer Policy Board estimated in 2003 that even modest efforts to implement known tactics for cancer prevention and early detection could result in up to a 29 percent drop in cancer deaths in about 20 years. The IOM's National Cancer Policy Forum, which succeeded the Board after it was disbanded in 2005, continued the Board's work to outline ways to increase screening in the U.S. On February 25 and 26, 2008, the Forum convened a workshop to discuss screening for colorectal cancer. Colorectal cancer screening remains low, despite strong evidence that screening prevents deaths. With the aim to make recommended colorectal cancer screening more widespread, the workshop discussed steps to be taken at the clinic, community, and health system levels. Workshop speakers, representing a broad spectrum of leaders in the field, identified major barriers to increased screening and described strategies to overcome these obstacles. This workshop summary highlights the information presented, as well as the subsequent discussion about actions needed to increase colorectal screening and, ultimately, to prevent more colorectal cancer deaths.

Rectal cancer is one of the most prevalent cancers world-wide. It is also a paradigm for multimodal management, as the combination of surgery, chemotherapy and radiotherapy is often necessary to achieve the optimal outcome. Recently, international experts met in Heidelberg, Germany to discuss the latest developments in the management of rectal cancer, including the anatomic and pathologic basis, staging tools, surgical concepts including fast-track surgery and laparoscopic resection, functional outcome after surgery and the role of radio- and chemotherapy. This monograph summarizes this meeting and gives an extensive overview of the current concepts in management of rectal cancer.

Together with Consulting Editor, Dr. Charles Lightdale, Dr. Doug Rex has put together an issue of Gastrointestinal Endoscopy Clinics that provides state-of-the-art clinical coverage of colorectal screening. Expert authors from all over the world have contributed clinical reviews that will be a staple for all practicing endoscopists. The articles are devoted to the following topics: What is organized screening and what is its value; Screening decisions in the opportunistic setting; The National Colorectal Cancer Round Table: Past performance and current and future goals; Proven strategies for increasing screening adherence; Colorectal cancer in persons under age 50: Seeking causes and solutions; Risk stratification strategies: From logistic regression to artificial intelligence; Cost-effectiveness of current screening tests; Quality in colorectal cancer screening; Screening for the serrated pathway; FIT: The world’s colorectal cancer screening test; Fecal DNA testing: What has it accomplished and where is it headed; Is bowel preparation without complete colon clearing a viable concept: Update on flexible sigmoidoscopy, CTC, and capsule colonoscopy; Evidenced based screening strategies for a positive family history; Aspirational ADR and ideal colonoscopy performance: How long can we go between colonoscopies; and How Artificial Intelligence will impact colonoscopy and colorectal cancer screening. Readers will come away with the clinical knowledge they need to improve outcomes in colon cancer screening and prevention.